177 related articles for article (PubMed ID: 36235226)
1. Deactivatable Bisubstrate Inhibitors of Protein Kinases.
Sõrmus T; Lavogina D; Enkvist E; Uri A; Viht K
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235226
[TBL] [Abstract][Full Text] [Related]
2. Bisubstrate inhibitors of protein kinases: from principle to practical applications.
Lavogina D; Enkvist E; Uri A
ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589
[TBL] [Abstract][Full Text] [Related]
3. Construction of Covalent Bisubstrate Inhibitor of Protein Kinase Reacting with Cysteine Residue at Substrate-Binding Site.
Sõrmus T; Lavogina D; Teearu A; Enkvist E; Uri A; Viht K
J Med Chem; 2022 Aug; 65(16):10975-10991. PubMed ID: 35960538
[TBL] [Abstract][Full Text] [Related]
4. Responsive microsecond-lifetime photoluminescent probes for analysis of protein kinases and their inhibitors.
Kasari M; Ligi K; Williams JA; Vaasa A; Enkvist E; Viht K; Pålsson LO; Uri A
Biochim Biophys Acta; 2013 Jul; 1834(7):1330-5. PubMed ID: 23499784
[TBL] [Abstract][Full Text] [Related]
5. Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase.
Viht K; Schweinsberg S; Lust M; Vaasa A; Raidaru G; Lavogina D; Uri A; Herberg FW
Anal Biochem; 2007 Mar; 362(2):268-77. PubMed ID: 17274940
[TBL] [Abstract][Full Text] [Related]
6. Efficient photocaging of a tight-binding bisubstrate inhibitor of cAMP-dependent protein kinase.
Sõrmus T; Lavogina D; Enkvist E; Uri A; Viht K
Chem Commun (Camb); 2019 Sep; 55(74):11147-11150. PubMed ID: 31464306
[TBL] [Abstract][Full Text] [Related]
7. Discovery of strong inhibitory properties of a monoclonal antibody of PKA and use of the antibody and a competitive photoluminescent orthosteric probe for analysis of the protein kinase.
Nonga OE; Lavogina D; Ivan T; Viht K; Enkvist E; Uri A
Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140427. PubMed ID: 32283249
[TBL] [Abstract][Full Text] [Related]
8. Bisubstrate inhibitor approach for targeting mitotic kinase Haspin.
Kestav K; Lavogina D; Raidaru G; Chaikuad A; Knapp S; Uri A
Bioconjug Chem; 2015 Feb; 26(2):225-34. PubMed ID: 25595038
[TBL] [Abstract][Full Text] [Related]
9. Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity.
Cozza G; Zanin S; Sarno S; Costa E; Girardi C; Ribaudo G; Salvi M; Zagotto G; Ruzzene M; Pinna LA
Biochem J; 2015 Nov; 471(3):415-30. PubMed ID: 26349539
[TBL] [Abstract][Full Text] [Related]
10. Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases.
Enkvist E; Kriisa M; Roben M; Kadak G; Raidaru G; Uri A
Bioorg Med Chem Lett; 2009 Nov; 19(21):6098-101. PubMed ID: 19800227
[TBL] [Abstract][Full Text] [Related]
11. Bivalent inhibitors of protein kinases.
Gower CM; Chang ME; Maly DJ
Crit Rev Biochem Mol Biol; 2014; 49(2):102-15. PubMed ID: 24564382
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases.
Lavogina D; Lust M; Viil I; König N; Raidaru G; Rogozina J; Enkvist E; Uri A; Bossemeyer D
J Med Chem; 2009 Jan; 52(2):308-21. PubMed ID: 19143565
[TBL] [Abstract][Full Text] [Related]
13. Bisubstrate fluorescent probes and biosensors in binding assays for HTS of protein kinase inhibitors.
Uri A; Lust M; Vaasa A; Lavogina D; Viht K; Enkvist E
Biochim Biophys Acta; 2010 Mar; 1804(3):541-6. PubMed ID: 19879386
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase structure and function analysis with chemical tools.
Shen K; Hines AC; Schwarzer D; Pickin KA; Cole PA
Biochim Biophys Acta; 2005 Dec; 1754(1-2):65-78. PubMed ID: 16213197
[TBL] [Abstract][Full Text] [Related]
15. Selective bisubstrate inhibitors with sub-nanomolar affinity for protein kinase Pim-1.
Ekambaram R; Enkvist E; Vaasa A; Kasari M; Raidaru G; Knapp S; Uri A
ChemMedChem; 2013 Jun; 8(6):909-13. PubMed ID: 23616352
[TBL] [Abstract][Full Text] [Related]
16. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in development of hetero-bivalent kinase inhibitors.
Lee S; Kim J; Jo J; Chang JW; Sim J; Yun H
Eur J Med Chem; 2021 Apr; 216():113318. PubMed ID: 33730624
[TBL] [Abstract][Full Text] [Related]
18. Oligo-aspartic acid conjugates with benzo[c][2,6]naphthyridine-8-carboxylic acid scaffold as picomolar inhibitors of CK2.
Vahter J; Viht K; Uri A; Enkvist E
Bioorg Med Chem; 2017 Apr; 25(7):2277-2284. PubMed ID: 28274673
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CREB phosphorylation by conjugates of adenosine analogues and arginine-rich peptides, inhibitors of PKA catalytic subunit.
Kriisa M; Sinijärv H; Vaasa A; Enkvist E; Kostenko S; Moens U; Uri A
Chembiochem; 2015 Jan; 16(2):312-9. PubMed ID: 25487811
[TBL] [Abstract][Full Text] [Related]
20. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies.
Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A
Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
